Cancer Family

Lymphocytic Neoplasm

HematologicNon-malignant3,037 active trials72 approved drugs345 evidence items

NCIt: C7065

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (351)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 26–50 of 351 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

PKMYT1 is a targetable vulnerability in del(17p) high-risk multiple myeloma.
Anaïs Schavgoulidze, Jian Cui, Jessica Encinas Mayoral et al. · Blood · Sep 17, 2026 · PMID 42237635 · candidate dictionary pubmed
Belantamab mafodotin plus venetoclax in t(11;14)-positive relapsed or refractory multiple myeloma - the BELI(E)VE trial.
Christoph Schaefers, Cyrus Khandanpour, Mathias Hänel et al. · BMC Cancer · Sep 16, 2026 · PMID 42786443 · candidate dictionary pubmed
The NSDHL/c-Myc/PKM2 Axis Drives Glycolytic Reprogramming and Tumor Growth in Multiple Myeloma.
Can Yue, Bei-Hui Huang, Lin Qi et al. · Int J Mol Sci · Sep 16, 2026 · PMID 42794667 · candidate dictionary pubmed
Innate immune dysregulation in multiple myeloma: molecular basis and mechanistic interventions.
Gang Wang, Hanlin Gao, Tianyi Xie et al. · Int Immunopharmacol · Sep 15, 2026 · PMID 42314557 · candidate dictionary pubmed
Imaging B cell maturation antigen in multiple myeloma.
Yangmeihui Song, Wenyu Song, Weibo Cai · J Clin Invest · Sep 15, 2026 · PMID 42741935 · candidate dictionary pubmed
A single-arm prospective phase I trial of 68Ga-PFBC01 PET/CT for multiple myeloma B cell maturation antigen imaging.
Tingfei Gu, Zhao Chen, Bo Tang et al. · J Clin Invest · Sep 15, 2026 · PMID 42378054 · candidate dictionary pubmed
Second Primary Malignancy Risk in Patients with Multiple Myeloma Receiving CAR T-cell Therapy or Other Systemic Anticancer Treatments: A Real-World Comparative Study.

Attaya Suvannasankha, Mengying Li, Omonefe Omofuma et al. · Clin Cancer Res · Sep 15, 2026 · PMID 42283723 · candidate dictionary pubmed

Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma.

Rafael R Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads et al. · Cancer Res · Sep 15, 2026 · PMID 42233980 · candidate dictionary pubmed

Early deep response to cilta-cel as 2nd CAR T-Cell therapy after CELMoD-based bridging for advanced multiple myeloma.

Henrik Niklas, Anna Bold, Simon Völkl et al. · Ann Hematol · Sep 15, 2026 · PMID 42747560 · candidate dictionary pubmed

Outcomes of stereotactic radiosurgery for spine multiple myeloma-a systematic review.

Muhammad Izhar, Yusuke S Hori, Ahed H Kattaa et al. · Neurosurg Rev · Sep 14, 2026 · PMID 42733030 · candidate dictionary pubmed

Multiple Myeloma-Derived Cellular Lipids Enhance Targeting and Efficacy of Nanoliposome Formulations In Vitro.

Mathew Amorin, Christina Tran, Eden Park et al. · Int J Mol Sci · Sep 13, 2026 · PMID 42794583 · candidate dictionary pubmed

Global prevalence trends and predictions of Hodgkin lymphoma from 1990 to 2021: age-period-cohort analysis and transnational inequality.

Wei-Li Wang, Shen-Sui Li, Dan Ma et al. · J Glob Health · Sep 11, 2026 · PMID 42726074 · candidate dictionary pubmed

Treatment Decisions in Multiple Myeloma.

Tarek H Mouhieddine, Kenneth C Anderson · N Engl J Med · Sep 10, 2026 · PMID 42715563 · candidate dictionary pubmed

Product-intrinsic NF-κB-driven transcriptional programs connote durability of CAR-T response in multiple myeloma.

Jerald D Noble, Barbara C Peixoto, Meghan A Menges et al. · Blood · Sep 10, 2026 · PMID 42275255 · candidate dictionary pubmed

Five-year survival outcomes of lisocabtagene maraleucel in R/R LBCL from the TRANSCEND NHL 001 study.

Jeremy S Abramson, Tanya Siddiqi, Leo I Gordon et al. · Blood · Sep 10, 2026 · PMID 42237652 · candidate dictionary pubmed

Cone-Beam Computed Tomography Imaging of Primary Non-Hodgkin Lymphoma of the Jaws: A 6-Case Series.

Emmanouil Chatzipetros, Konstantina-Eleni Alexiou, Kostas Tsiklakis et al. · Am J Case Rep · Sep 9, 2026 · PMID 42715158 · candidate dictionary pubmed

The Epigenetic Architecture of Classical Hodgkin Lymphoma: Lineage Erasure, Immune Escape, and Therapeutic Reprogramming.

Matei Seleusan, Diana Cenariu, Adrian-Bogdan Țigu et al. · Medicina (Kaunas) · Sep 9, 2026 · PMID 42796346 · candidate dictionary pubmed

E-lesion or stage IV disease? An ongoing unsettled issue in pediatric Hodgkin lymphoma.

Jennifer Seelisch, Christine Mauz-Koerholz, Kara M Kelly et al. · Blood Adv · Sep 8, 2026 · PMID 42361346 · candidate dictionary pubmed

EuroNet-PHL-LP1: complete resection or low-dose chemotherapy for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

Ananth Shankar, Judith Landman-Parker, Maurizio Mascarin et al. · Blood Adv · Sep 8, 2026 · PMID 42234940 · candidate dictionary pubmed

Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma.

Joseph P McGuirk, Armin Ghobadi, Carlos R Bachier et al. · Blood Adv · Sep 8, 2026 · PMID 42085626 · candidate dictionary pubmed

Adapting a mental health program for people with multiple myeloma and smouldering myeloma: a consumer-informed feasibility study.

Natalie Tuckey, Matthew Iasiello, Melissa Cantley et al. · Support Care Cancer · Sep 8, 2026 · PMID 42706438 · candidate dictionary pubmed

Heestermans R, Olsen C, Ameli S, et al. Blood-derived cell-free DNA is a superior biomarker for noninvasive DNA methylation profiling in multiple myeloma. Blood Adv. 2025;9(16):4306-4310.

· Blood Adv · Sep 8, 2026 · PMID 42664001 · candidate dictionary pubmed

TNFRSF17 genomic profiling guides retreatment with alternative BCMA-directed immunotherapies in multiple myeloma.

Benjamin Podvin, Holly Lee, Rémi Tilmont et al. · Blood Adv · Sep 8, 2026 · PMID 42418388 · candidate dictionary pubmed

Clinical course, risk factors, and therapeutic response in multiple myeloma with central nervous system involvement.

Alexander Xiao, Saurabh Zanwar, Yi Lin et al. · Blood Adv · Sep 8, 2026 · PMID 42348786 · candidate dictionary pubmed

Classic Hodgkin Lymphoma: A Review.

Kishan K Patel, Alison J Moskowitz · JAMA · Sep 8, 2026 · PMID 42545803 · candidate dictionary pubmed